Literature DB >> 27275089

How important is donor age in liver transplantation?

Alberto Lué1, Estela Solanas1, Pedro Baptista1, Sara Lorente1, Juan J Araiz1, Agustin Garcia-Gil1, M Trinidad Serrano1.   

Abstract

The age of liver donors has been increasing in the past several years because of a donor shortage. In the United States, 33% of donors are age 50 years or older, as are more than 50% in some European countries. The impact of donor age on liver transplantation (LT) has been analyzed in several studies with contradictory conclusions. Nevertheless, recent analyses of the largest databases demonstrate that having an older donor is a risk factor for graft failure. Donor age is included as a risk factor in the more relevant graft survival scores, such as the Donor Risk Index, donor age and Model for End-stage Liver Disease, Survival Outcomes Following Liver Transplantation, and the Balance of Risk. The use of old donors is related to an increased rate of biliary complications and hepatitis C virus-related graft failure. Although liver function does not seem to be significantly affected by age, the incidence of several liver diseases increases with age, and the capacity of the liver to manage or overcome liver diseases or external injuries decreases. In this paper, the importance of age in LT outcomes, the role of donor age as a risk factor, and the influence of aging on liver regeneration are reviewed.

Entities:  

Keywords:  Aging; Graft survival; Liver regeneration; Liver transplantation; Old donor

Mesh:

Year:  2016        PMID: 27275089      PMCID: PMC4886372          DOI: 10.3748/wjg.v22.i21.4966

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  67 in total

1.  Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).

Authors:  René Adam; Vincent Karam; Valérie Delvart; John O'Grady; Darius Mirza; Jurgen Klempnauer; Denis Castaing; Peter Neuhaus; Neville Jamieson; Mauro Salizzoni; Stephen Pollard; Jan Lerut; Andreas Paul; Juan Carlos Garcia-Valdecasas; Fernando San Juan Rodríguez; Andrew Burroughs
Journal:  J Hepatol       Date:  2012-05-16       Impact factor: 25.083

2.  Reperfusion damage to the bile canaliculi in transplanted human liver.

Authors:  J C Cutrin; D Cantino; F Biasi; E Chiarpotto; M Salizzoni; E Andorno; G Massano; G Lanfranco; M Rizzetto; A Boveris; G Poli
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

3.  Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.

Authors:  Marina Berenguer; Victoria Aguilera; Martín Prieto; Cecilia Ortiz; Maria Rodríguez; Federica Gentili; Blas Risalde; Angel Rubin; Raquel Cañada; Antonio Palau; Jose-Miguel Rayón
Journal:  Liver Transpl       Date:  2009-07       Impact factor: 5.799

4.  [Activity and results of liver transplantation in Spain during 1984-2012. Analysis of the Spanish Liver Transplant Registry].

Authors:  Valentín Cuervas-Mons; Gloria de la Rosa; Fernando Pardo; Fernando San Juan; Andrés Valdivieso
Journal:  Med Clin (Barc)       Date:  2014-11-13       Impact factor: 1.725

5.  The effects of immunosuppressive agents on the function of human hepatocytes in vitro.

Authors:  Trinidad Serrano; Ragai R Mitry; Claire Terry; Sharon C Lehec; Anil Dhawan; Robin D Hughes
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

6.  Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Yuxiang Sun; Jeffrey H Albrecht; Roy G Smith; Nikolai A Timchenko
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

7.  Donor age in living donor liver transplantation.

Authors:  T Ikegami; A Taketomi; R Ohta; Y Soejima; T Yoshizumi; M Shimada; Y Maehara
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

8.  Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications.

Authors:  Peter Abt; Michael Crawford; Niraj Desai; James Markmann; Kim Olthoff; Abraham Shaked
Journal:  Transplantation       Date:  2003-05-27       Impact factor: 4.939

9.  Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.

Authors:  Victor I Machicao; Hugo Bonatti; Murli Krishna; Bashar A Aqel; Frank J Lukens; Justin H Nguyen; Barry G Rosser; Raj Satyanarayana; Hani P Grewal; Winston R Hewitt; Denise M Harnois; Julia E Crook; Jeffery L Steers; Rolland C Dickson
Journal:  Transplantation       Date:  2004-01-15       Impact factor: 4.939

10.  Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry.

Authors:  René Adam; Paul McMaster; John G O'Grady; Denis Castaing; Jurgen L Klempnauer; Neville Jamieson; Peter Neuhaus; Jan Lerut; Mauro Salizzoni; Stephen Pollard; Ferdinand Muhlbacher; Xavier Rogiers; Juan Carlos Garcia Valdecasas; Joaquin Berenguer; Daniel Jaeck; Enrique Moreno Gonzalez
Journal:  Liver Transpl       Date:  2003-12       Impact factor: 5.799

View more
  17 in total

1.  Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.

Authors:  Emily D Bethea; Sumeyye Samur; Fasiha Kanwal; Turgay Ayer; Chin Hur; Mark S Roberts; Norah Terrault; Raymond T Chung; Jagpreet Chhatwal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-21       Impact factor: 11.382

Review 2.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

Review 3.  Enlarged selection criteria for hepatocellular cancer: is the upper limit needed?

Authors:  Andrea Peloso; Graziano Oldani
Journal:  Transl Gastroenterol Hepatol       Date:  2017-09-21

4.  Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.

Authors:  Yaara Leibovici-Weissman; Eytan Mor; Moshe Leshno; Amir Shlomai
Journal:  Dig Dis Sci       Date:  2017-01-04       Impact factor: 3.199

5.  LIVER TRANSPLANTATION: WILL XENOTRANSPLANTATION BE THE ANSWER TO THE DONOR ORGAN SHORTAGE?

Authors:  Robert L Carithers
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

Review 6.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

7.  Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.

Authors:  Georg Dultz; Barry I Graubard; Paul Martin; Martin-Walter Welker; Johannes Vermehren; Stefan Zeuzem; Katherine A McGlynn; Tania M Welzel
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

8.  Long-term results after transplantation of pediatric liver grafts from donation after circulatory death donors.

Authors:  Rianne van Rijn; Pieter E R Hoogland; Frank Lehner; Ernest L W van Heurn; Robert J Porte
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

9.  Significance of neutrophil microparticles in ischaemia-reperfusion: Pro-inflammatory effectors of endothelial senescence and vascular dysfunction.

Authors:  Ali El Habhab; Raed Altamimy; Malak Abbas; Mohamad Kassem; Lamia Amoura; Abdul Wahid Qureshi; Hanine El Itawi; Guillaume Kreutter; Sonia Khemais-Benkhiat; Fatiha Zobairi; Valérie B Schini-Kerth; Laurence Kessler; Florence Toti
Journal:  J Cell Mol Med       Date:  2020-06-10       Impact factor: 5.310

10.  Is there any correlation between liver graft regeneration and recipient's pretransplant skeletal muscle mass?-a study in extended left lobe graft living-donor liver transplantation.

Authors:  Riccardo Pravisani; Akihiko Soyama; Shinichiro Ono; Umberto Baccarani; Miriam Isola; Mitsuhisa Takatsuki; Masaaki Hidaka; Tomohiko Adachi; Takanobu Hara; Takashi Hamada; Florian Pecquenard; Andrea Risaliti; Susumu Eguchi
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.